CA3018043C - Formulations pharmaceutiques a liberation retardee comprenant de l'acide valproique, et leurs utilisations - Google Patents

Formulations pharmaceutiques a liberation retardee comprenant de l'acide valproique, et leurs utilisations

Info

Publication number
CA3018043C
CA3018043C CA3018043A CA3018043A CA3018043C CA 3018043 C CA3018043 C CA 3018043C CA 3018043 A CA3018043 A CA 3018043A CA 3018043 A CA3018043 A CA 3018043A CA 3018043 C CA3018043 C CA 3018043C
Authority
CA
Canada
Prior art keywords
vpa
acid
pharmaceutically acceptable
hours
dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3018043A
Other languages
English (en)
Other versions
CA3018043A1 (fr
Inventor
Nils Ove Gustafsson
Hans Roger Marcus Martensson
Niklas Bergh
Jonas Faijerson Saljo
Sverker Jern
Original Assignee
Cereno Scientific AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cereno Scientific AB filed Critical Cereno Scientific AB
Priority claimed from PCT/GB2017/051002 external-priority patent/WO2017175013A1/fr
Publication of CA3018043A1 publication Critical patent/CA3018043A1/fr
Application granted granted Critical
Publication of CA3018043C publication Critical patent/CA3018043C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

La présente invention concerne une formulation pharmaceutique comportant un ou plusieurs composants comprenant l'acide valproïque (VPA) et/ou un sel pharmaceutiquement acceptable de celui-ci ; et un ou plusieurs acides secondaires, et comprenant facultativement un ou plusieurs excipients pharmaceutiquement acceptables. L'invention concerne en outre des utilisations de telles formulations.
CA3018043A 2016-04-08 2017-04-10 Formulations pharmaceutiques a liberation retardee comprenant de l'acide valproique, et leurs utilisations Active CA3018043C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1606197.0 2016-04-08
GB201606197 2016-04-08
PCT/GB2017/051002 WO2017175013A1 (fr) 2016-04-08 2017-04-10 Formulations pharmaceutiques à libération retardée comprenant de l'acide valproïque, et leurs utilisations

Publications (2)

Publication Number Publication Date
CA3018043A1 CA3018043A1 (fr) 2017-10-12
CA3018043C true CA3018043C (fr) 2026-06-02

Family

ID=